Clinical Trial Update: Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 study of augmerosen with fludarabine and cytarabine in patients with refractory or relapsed acute myeloid leukemia or acute lymphoblastic leukemia; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Augmerosen
• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Leukemia | Phase 1 | Status: COMPLETED